Bis dihydropyrimidine: synthesis and antimycobacterial activity.

J Enzyme Inhib Med Chem

New Drug Discovery Research, Department of Medicinal Chemistry, Alwar Pharmacy College, Alwar, Rajasthan, India.

Published: February 2011

A series of bis dihydropyrimidine compounds were synthesised by reacting dapsone with acetylacetoacetate to produce N1-4-[4-(2-oxopropylcarboxamido) phenylsulphonyl] phenyl-3-oxobutanamide, then treated with guanidine hydrochloride and an appropriate aldehyde with a catalytic amount of p-toluene sulphonic acid (PTSA) in the presence of methanol to afford the title compounds. The synthesised compounds were evaluated for their antimycobacterial activity against Mycobacterium tuberculosis H(37)Rv and isoniazid (INH) resistant M. tuberculosis. Among the synthesised compounds, compound N5-(4-4-[6-(4-fluorophenyl)-2-imino-4-methyl-1,2,3,4-tetrahydro-5-pyrimidinylcarboxamido]phenylsulphonylphenyl)-6-(4-fluorophenyl)-2-imino-4-methyl-1,2,3,4-tetrahydro-5-pyrimidine carboxamide (3g) was found to be the most promising compound with activity against M. tuberculosis H(37)Rv and INH resistant M. tuberculosis with a minimum inhibitory concentration (MIC) between 0.08 and 0.10 μM.

Download full-text PDF

Source
http://dx.doi.org/10.3109/14756366.2010.482046DOI Listing

Publication Analysis

Top Keywords

bis dihydropyrimidine
8
antimycobacterial activity
8
compounds synthesised
8
synthesised compounds
8
tuberculosis h37rv
8
inh resistant
8
resistant tuberculosis
8
dihydropyrimidine synthesis
4
synthesis antimycobacterial
4
activity series
4

Similar Publications

Two Thiophene-Functionalized Co-MOFs as Green Heterogeneous Catalysts for the Biginelli Reaction.

Inorg Chem

October 2024

School of Chemistry and Chemical Engineering, University of Jinan, Jinan, Shandong 250022, P. R. China.

Two Co(II) metal-organic frameworks (Co-MOFs), namely, [Co(DMTDC)(bimb)] () and {[Co(DPTDC)(bimb)(HO)]·2DMF} () (HDMTDC = 3,4-dimethylthieno[2,3-]thiophene-2,5-dicarboxylic acid, HDPTDC = 3,4-diphenylthieno[2,3-]thiophene-2,5-dicarboxylic acid, bimb = 1,4-bis((1-imidazol-1-yl)methyl)benzene), were obtained by the reaction of flexible N-containing ligand bimb and two structurally related thiophene-containing ligands HDMTDC and HDPTDC, respectively. These Co-MOFs displayed a 3D framework and porous structure, respectively. and the activated sample could act as green heterogeneous catalysts for the one-pot multicomponent Biginelli reaction, specifically the dehydration condensation process involving aldehydes, acetoacetates, and urea to yield dihydropyrimidin-2(1)-ones.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates how aloe-emodin (AE) nanoparticles can potentially protect the brain during a stroke by examining their interactions with the target protein myeloperoxidase (MPO) through advanced simulations, showing AE binds more effectively to MPO than a comparative compound (CCl).
  • - It is proposed that converting AE into nanoparticles can enhance its bioavailability, as results indicate that aloe-emodin nanoparticles (AENP) significantly improve various health parameters in stroke-affected rats compared to standard AE treatment.
  • - The research findings suggest that AENP treatment not only reduces the size of brain damage but also stabilizes heart and brain functions, leading to better overall outcomes for stroke-affected rats while highlighting severe damage and abnormalities observed
View Article and Find Full Text PDF

Ursodeoxycholic acid (UDCA) and acetoacetate are natural compounds present in the human intestine and blood, respectively. A number of studies highlighted that besides their well-known primary biological roles, both compounds possess the ability to influence a variety of cellular processes involved in the etiology of various diseases. These reasons suggested the potential of acetoacetate-UDCA hybrids as possible therapeutic agents and prompted us to develop a synthetic strategy to selectively derivatize the hydroxyl groups of the bile acid with acetoacetyl moieties.

View Article and Find Full Text PDF

A simple and novel methodology has been developed for the synthesis of 1,3-bis(carboxymethyl)imidazolium chloride [BCMIM][Cl] salt. The ionic salt [BCMIM][Cl] catalyzed the reaction among arylaldehydes; the substituted 1,3-dicarbonyl compounds and urea/thiourea at 80 °C with 5 mol % under neat condition provided the substituted dihydropyrimidin-2(1)-one/thiones in the synthesis step with yields of up to 96%. In addition, we synthesized the commercially available drug Monastrol by employing this methodology.

View Article and Find Full Text PDF

Novel class of amino pyrimidine thioglycoside derivatives were designed from sodium 2-cyano-3-(arylamino)prop-1-ene-1,1-bis(thiolate) and guanidine hydrochloride to afford the corresponding sodium 2,6-diamino-5-aryl-1,2-dihydropyrimidine-4-thiolate , which in coupling with peracylated -D-gluco- and galactopyranosyl bromides in DMF gave the corresponding pyrimidine thioglycosides . Acidification of 2,6-diamino-5-aryl-1,2-dihydropyrimidine-4-thiolate salts with hydrochloric acid formed the corresponding pyrimidine-4-thioles . The latter were stirred with peracetylated halo sugars α-D-gluco- and galacto-pyranosyl bromides in sodium hydride and DMF to yield the pyrimidine thioglycosides .

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!